Total Payments
$9,328
2024 Payments
$717.15
Companies
29
Transactions
132
Medicare Patients
4,850
Medicare Billing
$314,618
Payment Breakdown by Category
Other$6,401 (68.6%)
Food & Beverage$2,927 (31.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $6,401 | 1 | 68.6% |
| Food and Beverage | $2,927 | 131 | 31.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $6,634 | 7 | $0 (2022) |
| ABBVIE INC. | $482.25 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301.04 | 15 | $0 (2024) |
| Lilly USA, LLC | $284.52 | 10 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $188.43 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $167.47 | 9 | $0 (2024) |
| Amgen Inc. | $134.18 | 5 | $0 (2024) |
| GENZYME CORPORATION | $131.40 | 6 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $98.42 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.03 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $717.15 | 34 | GENZYME CORPORATION ($101.37) |
| 2023 | $639.52 | 29 | ABBVIE INC. ($101.36) |
| 2022 | $489.31 | 26 | Novartis Pharmaceuticals Corporation ($68.45) |
| 2021 | $6,757 | 18 | Biofrontera Inc. ($6,429) |
| 2020 | $180.83 | 9 | Sun Pharmaceutical Industries Inc. ($36.67) |
| 2019 | $189.17 | 8 | Lilly USA, LLC ($100.62) |
| 2018 | $198.39 | 7 | Lilly USA, LLC ($112.57) |
| 2017 | $157.13 | 1 | Biofrontera Inc. ($157.13) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.03 | General |
| 11/19/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $24.54 | General |
| Category: Wound Care | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/29/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Dermatology | ||||||
| 10/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ACNE | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: DERMATOLOGY | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: Immunology | ||||||
| 06/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Immunology | ||||||
| 06/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Immunology | ||||||
| 06/04/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 05/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,240 | 2,178 | $179,880 | $80,290 |
| 2022 | 16 | 1,442 | 2,479 | $216,792 | $94,923 |
| 2021 | 11 | 1,077 | 2,154 | $151,791 | $70,256 |
| 2020 | 11 | 1,091 | 1,998 | $164,358 | $69,150 |
Total Patients
4,850
Total Services
8,809
Medicare Billing
$314,618
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 246 | 286 | $30,030 | $14,523 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 176 | $26,400 | $14,135 | 53.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 146 | 227 | $26,332 | $11,969 | 45.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 209 | 250 | $23,500 | $8,532 | 36.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 100 | 109 | $16,350 | $8,210 | 50.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 78 | 87 | $13,224 | $5,335 | 40.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 174 | 890 | $15,130 | $3,976 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $8,493 | $3,623 | 42.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $5,852 | $2,790 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,129 | $2,380 | 46.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 18 | $4,248 | $2,200 | 51.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 14 | $2,870 | $1,610 | 56.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 27 | $2,322 | $1,007 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 351 | 422 | $44,310 | $22,939 | 51.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 238 | 292 | $27,448 | $10,170 | 37.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 41 | 43 | $17,974 | $8,651 | 48.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 98 | 115 | $17,250 | $8,548 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 118 | $17,700 | $8,389 | 47.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 109 | 117 | $17,784 | $7,210 | 40.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 112 | 157 | $11,548 | $4,811 | 41.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 204 | 1,007 | $17,119 | $4,620 | 27.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 11 | 15 | $8,160 | $4,500 | 55.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 58 | 58 | $8,642 | $4,018 | 46.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 32 | 34 | $11,186 | $3,097 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $6,467 | $2,560 | 39.6% |
About Dr. Ryan Freeland, MD
Dr. Ryan Freeland, MD is a Dermatology healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942265178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Freeland, MD has received a total of $9,328 in payments from pharmaceutical and medical device companies, with $717.15 received in 2024. These payments were reported across 132 transactions from 29 companies. The most common payment nature is "Debt forgiveness" ($6,401).
As a Medicare-enrolled provider, Freeland has provided services to 4,850 Medicare beneficiaries, totaling 8,809 services with total Medicare billing of $314,618. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Wyoming, MI
- Active Since 04/19/2006
- Last Updated 02/28/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942265178
Products in Payments
- AMELUZ (Drug) $6,447
- DUPIXENT (Biological) $297.36
- TALTZ (Drug) $284.52
- SKYRIZI (Biological) $220.19
- Ameluz (Drug) $186.78
- Sotyktu (Drug) $167.47
- COSENTYX (Biological) $151.85
- RINVOQ (Biological) $125.21
- Otezla (Drug) $109.61
- COSENTYX (Drug) $106.71
- Humira (Biological) $85.61
- HADLIMA (Drug) $70.35
- ADBRY (Biological) $60.07
- SPEVIGO (Drug) $57.79
- SILIQ (Drug) $57.57
- OPZELURA (Drug) $54.98
- Cimzia (Drug) $54.67
- TREMFYA (Drug) $43.82
- BLU-U (Medical Supply) $43.33
- EUCRISA (Drug) $43.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.